Effect of arginine on angiogenesis induced by human colon cancer: In vitro and in vivo studies

Journal of Nutritional Biochemistry

Volumn 21, Issue 6, 2010, Pages 538-543

  Yeh, Chiu Li ^a,b   Pai, Man Hui ^b   Li, Cheng Chung ^b   Tsai, Yu Ling ^a   Yeh, Sung Ling ^b  

^a CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Angiogenic protein; Arginine; Inducible nitric oxide; Natural killer cell; Nude mice; SW480

Indexed keywords

ARGININE; BASIC FIBROBLAST GROWTH FACTOR; CD31 ANTIGEN; CD51 ANTIGEN; CD61 ANTIGEN; GELATINASE A; GELATINASE B; INDUCIBLE NITRIC OXIDE SYNTHASE; VASCULOTROPIN; BETA3 INTEGRIN; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER INHIBITION; COLON CANCER; CONTROLLED STUDY; DIET THERAPY; HUMAN; HUMAN CELL; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PROTEIN EXPRESSION; ANIMAL; BIOSYNTHESIS; CANCER TRANSPLANTATION; COLON TUMOR; CYTOLOGY; IN VITRO STUDY; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; PATHOLOGY;

ANIMALS; ARGININE; COLONIC NEOPLASMS; HUMANS; INTEGRIN ALPHAV; INTEGRIN BETA3; KILLER CELLS, NATURAL; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE SYNTHASE TYPE II; VASCULAR ENDOTHELIAL GROWTH FACTOR A; IN VITRO TECHNIQUES;

MUS; MUS MUSCULUS;

EID: 77952883869     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2009.03.005     Document Type: Article

References (41)

1. de Jonge W.J., Marescau B., D'Hooge R., De Deyn P.P., Hallemeesch M.M., Deutz N.E., et al. Overexpression of arginase alters circulating and tissue amino acids and guanidino compounds and affects neuromotor behavior in mice. J Nutr 2001, 131:2732-2740.
2. Kirk S.J., Regan M.C., Wasserkrug H.L., Sodeyama M., Barbul A. Arginine enhances T-cell responses in athymic nude mice. J Parenter Enteral Nutr 1992, 16:429-432.
3. Gianotti L., Alexander J.W., Pyles T., Fukushima R. Arginine-supplemented diets improve survival in gut-derived sepsis and peritonitis by modulating bacterial clearance. The role of nitric oxide. Ann Surg 1993, 217:644-653.
4. Daly J.M., Reynolds J., Thom A., Kinsley L., Dietrick-Gallagher M., Shou J., et al. Immune and metabolic effects of arginine in the surgical patient. Ann Surg 1988, 208:512-523.
5. Evoy D., Lieberman M.D., Fahey T.J., Daly J.M. Immunonutrition: the role of arginine. Nutrition 1998, 14:611-617.
6. De-Souza D.A., Greene L.J. Pharmacological nutrition after burn injury. J Nutr 1998, 128:797-803.
7. Fukumura D., Yonei Y., Kurose I., Saito H., Ohishi T., Higuchi H., et al. Role in nitric oxide in Kupffer cell-mediated hepatoma cell cytotoxicity in vitro and ex vivo. Hepatology 1996, 24:141-149.
8. Cifone M.G., Festuccia C., Cironi L., Cavallo G., Chessa M.A., Pensa V., et al. Induction of the nitric oxide-synthesizing pathway in fresh and interleukin 2-cultured rat natural killer cells. Cell Immunol 1994, 157:181-194.
9. Mordan L.J., Burnett T.S., Zhang L.X., Tom J., Cooney R.V. Inhibitors of endogenous nitrogen oxide formation block the promotion of neoplastic transformation in C3H 10T1/2 fibroblasts. Carcinogenesis 1993, 14:1555-1559.
10. Gottke M., Chadee K. Exogenous nitric oxide stimulates mucin secretion from LS174T colonic adenocarcinoma cells. Inflamm Res 1996, 45:209-212.
11. Casas-Rodera P., Gomez-Candela C., Benitez S., Mateo R., Armero M., Castillo R., et al. Immunoenhanced enteral nutrition formulas in head and neck cancer surgery: a prospective, randomized clinical trial. Nutr Hosp 2008, 23:105-110.
12. Ma Q., Williamson K.E., O'Rourke D., Rowlands B.J. The effects of l-arginine on crypt cell hyperproliferation in colorectal cancer. J Surg Res 1999, 81:181-188.
13. Ma Q., Wang Y., Gao X., Ma Z., Song Z. l-Arginine reduces cell proliferation and ornithine decarboxylase activity in patients with colorectal adenoma and adenocarcinoma. Clin Cancer Res 2007, 13:7407-7412.
14. Vissers Y.L., Dejong C.H., Luiking Y.C., Fearon K.C., von Meyenfeldt M.F., Deutz N.E. Plasma arginine concentrations are reduced in cancer patients: evidence for arginine deficiency?. Am J Clin Nutr 2005, 81:1142-1146.
15. Jyothi M.D., Khar A. Induction of nitric oxide production by natural killer cells: its role in tumor cell death. Nitric Oxide 1999, 3:409-418.
16. Jaffe E.A., Nachman R.L., Becker C.G., Minick C.R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973, 52:2745-2756.
17. Languino L.R., Duperray A., Joganic K.J., Fornaro M., Thornton G.B., Altieri D.C. Regulation of leukocyte-endothelium interaction and leukocyte transendothelial migration by intercellular adhesion molecule 1-fibrinogen recognition. Proc Natl Acad Sci U S A 1995, 92:1505-1509.
18. Yeh C.L., Lee C.H., Chen S.C., Hou Y.C., Yeh S.L. Effects of arginine-containing total parenteral nutrition on N balance and phagocytic activity in rats undergoing a partial gastrectomy. Br J Nutr. 2005, 93:267-272.
19. Shang H.F., Wang Y.Y., Lai Y.N., Chiu W.C., Yeh S.L. Effects of arginine supplementation on mucosal immunity in rats with septic peritonitis. Clin Nutr 2004, 23:561-569.
20. Chang L., Gusewitch G.A., Chritton D.B., Folz J.C., Lebeck L.K., Nehlsen-Cannarella S.L. Rapid flow cytometric assay for the assessment of natural killer cell activity. J Immunol Methods 1993, 166:45-54.
21. Rose D.P., Connolly J.M. Regulation of tumor angiogenesis by dietary fatty acids and eicosanoids. Nutr Cancer 2000, 37:119-127.
22. Dobbs S.P., Hewett P.W., Johnson I.R., Carmichael J., Murray J.C. Angiogenesis is associated with vascular endothelial growth factor expression in cervical intraepithelial neoplasia. Br J Cancer 1997, 76:1410-1415.
23. Asahara T., Bauters C., Zheng L.P., Takeshita S., Bunting S., Ferrara N., et al. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 1995, 92:II365-II371.
24. Vihinen P., Kahari V.M. Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int J Cancer 2002, 99:157-166.
25. Brooks P.C., Clark R.A., Cheresh D.A. Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 1994, 264:569-571.
26. Sipkins D.A., Cheresh D.A., Kazemi M.R., Nevin L.M., Bednarski M.D., Li K.C. Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. Nat Med 1998, 4:623-626.
27. Ebos J.M., Lee C.R., Bogdanovic E., Alami J., Van Slyke P., Francia G., et al. Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth. Cancer Res 2008, 68:521-529.
28. Messina E.J., Weiner R., Kaley G. Prostaglandins and local circulatory control. Fed Proc 1976, 35:2367-2375.
29. Albelda S.M., Oliver P.D., Romer L.H., Buck C.A. Endo CAM a novel endothelial cell-cell adhesion molecule. J Cell Biol 1990, 110:1227-1237.
30. Dimaio T.A., Wang S., Huang Q., Scheef E.A., Sorenson C.M., Sheibani N. Attenuation of retinal vascular development and neovascularization in PECAM-1-deficient mice. Dev Biol 2008, 315:72-88.
31. Swaffar D.S., Ang C.Y., Desai P.B., Rosenthal G.A. Inhibition of the growth of human pancreatic cancer cells by the arginine antimetabolite l-canavanine. Cancer Res 1994, 54:6045-6048.
32. Park K.G., Heys S.D., Blessing K., Kelly P., McNurlan M.A., Eremin O., et al. Stimulation of human breast cancers by dietary l-arginine. Clin Sci (Lond) 1992, 82:413-417.
33. Radomski M.W., Jenkins D.C., Holmes L., Moncada S. Human colorectal adenocarcinoma cells: differential nitric oxide synthesis determines their ability to aggregate platelets. Cancer Res 1991, 51:6073-6078.
34. Yim C.Y., Bastian N.R., Smith J.C., Hibbs J.B., Samlowski W.E. Macrophage nitric oxide synthesis delays progression of ultraviolet light-induced murine skin cancers. Cancer Res 1993, 53:5507-5511.
35. Scott D.J., Hull M.A., Cartwright E.J., Lam W.K., Tisbury A., Poulsom R., et al. Lack of inducible nitric oxide synthase promotes intestinal tumorigenesis in the Apc(Min/+) mouse. Gastroenterology 2001, 121:889-899.
36. Yerushalmi H.F., Besselsen D.G., Ignatenko N.A., Blohm-Mangone K.A., Padilla-Torres J.L., Stringer D.E., et al. The role of NO synthases in arginine-dependent small intestinal and colonic carcinogenesis. Mol Carcinogen 2006, 45:93-105.
37. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989, 47:187-376.
38. Park K.G., Hayes P.D., Garlick P.J., Sewell H., Eremin O. Stimulation of lymphocyte natural cytotoxicity by l-arginine. Lancet 1991, 337:645-646.
39. Xiao L., Eneroth P.H., Qureshi G.A. Nitric oxide synthase pathway may mediate human natural killer cell cytotoxicity. Scand J Immunol 1995, 42:505-511.
40. Reynolds J.V., Daly J.M., Shou J., Sigal R., Ziegler M.M., Naji A. Immunologic effects of arginine supplementation in tumor-bearing and non-tumor-bearing hosts. Ann Surg 1990, 211:202-210.
41. Brittenden J., Park K.G., Heys S.D., Ross C., Ashby J., Ah-See A., Eremin O. l-Arginine stimulates host defenses in patients with breast cancer. Surgery 1994, 115:205-212.